Cargando…
In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9
In vivo mutagenesis systems accelerate directed protein evolution but often show restricted capabilities and deleterious off-site mutations on cells. To overcome these limitations, here we report an in vivo platform to diversify specific DNA segments based on protein fusions between various base dea...
Autores principales: | Álvarez, Beatriz, Mencía, Mario, de Lorenzo, Víctor, Fernández, Luis Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755918/ https://www.ncbi.nlm.nih.gov/pubmed/33353963 http://dx.doi.org/10.1038/s41467-020-20230-z |
Ejemplares similares
-
Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein
por: Lei, Yong, et al.
Publicado: (2017) -
Highly efficient and precise base editing by engineered dCas9-guide tRNA adenosine deaminase in rats
por: Ma, Yuanwu, et al.
Publicado: (2018) -
dCas9 regulator to neutralize competition in CRISPRi circuits
por: Huang, Hsin-Ho, et al.
Publicado: (2021) -
Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
por: O’Geen, Henriette, et al.
Publicado: (2019) -
Metabolically-targeted dCas9 expression in bacteria
por: Pellegrino, Gregory M, et al.
Publicado: (2023)